188 related articles for article (PubMed ID: 11835343)
21. Coagulation system activity before coronary artery bypass surgery for unstable angina.
Bjessmo S; Ivert T; Egberg N
Scand Cardiovasc J; 2001 Sep; 35(4):280-4. PubMed ID: 11759123
[TBL] [Abstract][Full Text] [Related]
22. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
23. Hematologic profile and lymphocyte subpopulations in hemoglobin SC disease: comparison with hemoglobin SS and black controls. The Transfusion Safety Study Group.
Wong WY; Zhou Y; Operskalski EA; Hassett J; Powars DR; Mosley JW
Am J Hematol; 1996 Jul; 52(3):150-4. PubMed ID: 8756079
[TBL] [Abstract][Full Text] [Related]
24. The coagulopathy in acute head injury: comparison of cerebral versus peripheral measurements of haemostatic activation markers.
Murshid WR; Gader AG
Br J Neurosurg; 2002 Aug; 16(4):362-9. PubMed ID: 12389889
[TBL] [Abstract][Full Text] [Related]
25. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
26. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
27. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
28. Fibrin formation and degradation in patients with arteriosclerotic disease.
Herren T; Stricker H; Haeberli A; Do DD; Straub PW
Circulation; 1994 Dec; 90(6):2679-86. PubMed ID: 7994808
[TBL] [Abstract][Full Text] [Related]
29. Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
Chojnowski K; Treliński J; Wawrzyniak E; Sobolewska M; Mielicki W
Neoplasma; 2002; 49(3):155-8. PubMed ID: 12098000
[TBL] [Abstract][Full Text] [Related]
30. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
[TBL] [Abstract][Full Text] [Related]
31. Alpha thalassaemia in adults with sickle-cell trait.
Steinberg MH; Adams JG; Dreiling BJ
Br J Haematol; 1975 May; 30(1):31-7. PubMed ID: 1191571
[TBL] [Abstract][Full Text] [Related]
32. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
Topper MJ; Prasse KW
Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
[TBL] [Abstract][Full Text] [Related]
33. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
34. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
[TBL] [Abstract][Full Text] [Related]
36. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
[TBL] [Abstract][Full Text] [Related]
37. Protein S deficiency in sickle cell anemia.
Francis RB
J Lab Clin Med; 1988 May; 111(5):571-6. PubMed ID: 2966224
[TBL] [Abstract][Full Text] [Related]
38. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
Boisclair MD; Ireland H; Lane DA
Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
[TBL] [Abstract][Full Text] [Related]
39. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
Kobayashi T; Terao T
Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
[TBL] [Abstract][Full Text] [Related]
40. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura.
Brendel-Müller K; Hahn A; Schneppenheim R; Santer R
Pediatr Nephrol; 2001 Dec; 16(12):1084-8. PubMed ID: 11793106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
